- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Remus Pharmaceuticals Ltd (REMP)
Track today's live Remus Pharmaceuticals (REMP) share price, performance and key data on this page with our current NSE:REMP stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Remus Pharmaceuticals share price on the NSE exchange. Use the dropdown to switch exchange for the REMP share price, head to our technical summary section, which provides analysis on Remus Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Remus Pharmaceuticals (REMP) stock price today with other investors in the Remus Pharmaceuticals NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:REMP share price (ISIN: INE0O5T01011) to enhance your trading decisions with our free investment tools and resources.
What Is the Remus Pharmaceuticals Ltd Share Price Today?
The Remus Pharmaceuticals share price today is 890.10.
What Is the Stock Symbol for Remus Pharmaceuticals Ltd
The stock symbol (or 'ticker') for Remus Pharmaceuticals Ltd is "REMP."
What Stock Exchange Does Remus Pharmaceuticals Ltd Trade On?
Remus Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Remus Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Remus Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:REMP share price (ISIN: INE0O5T01011) to enhance your trading decisions with our free investment tools and resources.
What Is the Remus Pharmaceuticals Ltd Share Price Today?
The Remus Pharmaceuticals share price today is 890.10.
What Is the Stock Symbol for Remus Pharmaceuticals Ltd
The stock symbol (or 'ticker') for Remus Pharmaceuticals Ltd is "REMP."
What Stock Exchange Does Remus Pharmaceuticals Ltd Trade On?
Remus Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Remus Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Remus Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
NSE
Currency in INR
890.10
+9.50(+1.08%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
890.10
905.00
52 wk Range
580.00
1,039.00
REMUS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
890.10905.00
52 wk Range
580.001,039.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
REMUS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
20/05/2026
EPS / Forecast
20.86 / --
Revenue / Forecast
4.57B / --
Compare REMUS to Peers and Sector
Metrics to compare | REMUS | Peers Peers - average of corresponding metrics from companies closely matching REMUS: 544143, NEPHROCARE, 536565, 531099, NEULANDLAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipREMUSPeersSector |
|---|---|---|---|---|
P/E Ratio | 28.1x | 43.7x | −0.3x | |
PEG Ratio | −0.77 | 0.82 | 0.00 | |
Price/Book | 3.0x | 4.6x | 2.6x | |
Price / LTM Sales | 1.2x | 3.9x | 2.9x | |
Upside (Analyst Target) | - | 27.1% | 65.4% | |
Fair Value Upside | Unlock | 2.0% | 8.9% | Unlock |
Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceutical products and allied products in India and internationally. It is involved in trading of active pharmaceutical ingredients, as well as provides technical and consultancy services to various distributors and contract manufacturing services. The company also offers tablet, hard and soft gel capsules, liquid, dry powder, lyophilized injections, as well as pre-filled syringe, infusions, inhalers, nebulizers, nasal sprays, topical sprays, respules, syrups and oral suspensions, creams, gels, ointments, topical solutions, transdermal patches, sachets, ovules, suppositories, and ophthalmic and other specialised forms. It also exports its products. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Remus Pharmaceuticals (NSE: REMUS) Share Price Today?
The Remus Pharmaceuticals stock price today is 890.10 INR.
What Stock Exchange Does Remus Pharmaceuticals (REMUS) Trade On?
Remus Pharmaceuticals is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Remus Pharmaceuticals?
The stock symbol (also called a 'ticker') for Remus Pharmaceuticals is "REMUS."
Does Remus Pharmaceuticals Pay Dividends? What’s The Current REMUS Dividend Yield?
Yes, REMUS Pays Dividends to its Shareholders. The current Remus Pharmaceuticals dividend yield is 0.1%%.
What Is the Current Remus Pharmaceuticals Market Capitalisation?
As of today, Remus Pharmaceuticals (NSE: REMUS) market cap is 10.38B INR.
What Is Remus Pharmaceuticals's (REMUS) Earnings Per Share (TTM)?
The Remus Pharmaceuticals EPS is currently 31.39 (Trailing Twelve Months).
Is REMUS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Remus Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for REMUS stock is Sell.
How Many Times Has Remus Pharmaceuticals Stock Split?
Remus Pharmaceuticals has split 2 times. (See the REMUS stock split history page for full effective split date and price information.)
How Many Employees Does Remus Pharmaceuticals Have?
Remus Pharmaceuticals has 69 employees, based on their latest Companies House report.
What is the current trading status of Remus Pharmaceuticals (NSE: REMUS)?
As of 26/10/2026, Remus Pharmaceuticals (REMUS) is trading at a share price of 890.10 INR, with a previous close of 880.60 INR. The stock has fluctuated within a day range of 890.10 INR to 905.00 INR, while its 52-week range spans from 580.00 INR to 1,039.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.